Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpire Healthcare Share News (SPI)

Share Price Information for Spire Healthcare (SPI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 248.00
Bid: 247.50
Ask: 248.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.202%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 248.00
SPI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Spire Healthcare Says Operational Changes Bear Fruit; Retains Guidance

Mon, 16th Sep 2019 09:10

(Alliance News) - Hospital group Spire Healthcare Group PLC on Monday reiterated its annual guidance as it swung to profit in the first half of 2019, crediting self-help.

London-listed shares in Spire were down 1.9% at 122.84 pence each in morning trade.

"This was a good performance with clear signs of our strategic and operational initiatives bearing fruit. We promised 2019 would be a year of stabilisation with revenue growth, continued quality improvement, cash generation and net debt reduction. All have been achieved in first half, with good operating profit performance," said Spire Chief Executive Justin Ash.

For the half-year ended June 30, the company recorded pretax profit of GBP9.6 million versus a pretax loss of GBP2.2 million a year before. Stripping out exceptional items, pretax profit fell 24% year-on-year to GBP10 million.

First half revenue was up 3.4% to GBP491.6 million from GBP475.6 million last year. Revenue from the private medical insurance division increased 5.1% year-on-year to GBP247.0 million, while the self-pay business recorded a 1.4% revenue rise to GBP88.6 million.

"We saw growth in both private insurance and self-pay, with a particularly strong result in private insurance reflecting rising consumer awareness following our marketing campaigns. NHS revenue in the period also outperformed expectations as we worked in close partnership with our local trusts and Clinical Commissioning Groups to selectively open new services that respond to their changing needs. We continue to develop our private revenue streams in key areas such as oncology, including working towards a partnership with GenesisCare to create a national end-to-end private cancer treatment pathway," said Ash.

Spire declared an interim dividend of 1.3 pence, unchanged from last year.

The company said its full-year guidance is reiterated. It predicted continued revenue growth in 2019, offset by product mix effects and planned investments.

With Spire's 2018 results in February, Ash had said: "We are taking a measured approach to 2019, which will be a year of consolidation. We expect modest revenue growth, and will see the full year effect of investments coming through, whilst we will continue to achieve further efficiencies. We are focused on cash generation and debt reduction, placing Spire in a strong position for future [earnings before interest, tax, depreciation and amortisation] growth."

More News
21 Apr 2021 09:42

BROKER RATINGS: Deutsche Bank starts coverage on BP and Shell at buy

BROKER RATINGS: Deutsche Bank starts coverage on BP and Shell at buy

Read more
9 Apr 2021 13:09

Friday broker round-up

(Sharecast News) - Hilton Food Group: RBC Capital Markets upgrades to outperform with a target price of 1,500p.

Read more
9 Apr 2021 09:43

BROKER RATINGS: Berenberg upgrades Marston's and downgrades City Pub

BROKER RATINGS: Berenberg upgrades Marston's and downgrades City Pub

Read more
29 Mar 2021 09:51

PRESS: Ian Cheshire puts name forward to be BT chair - Telegraph

PRESS: Ian Cheshire puts name forward to be BT chair - Telegraph

Read more
5 Mar 2021 09:39

BROKER RATINGS: JPMorgan neutral on Aston Martin; CRH targets lifted

BROKER RATINGS: JPMorgan neutral on Aston Martin; CRH targets lifted

Read more
4 Mar 2021 11:09

SMALL-CAP WINNERS & LOSERS: Tyman rises after second half recovery

SMALL-CAP WINNERS & LOSERS: Tyman rises after second half recovery

Read more
4 Mar 2021 10:47

Spire Healthcare taps Ian Cheshire as chair as swings to annual loss

Spire Healthcare taps Ian Cheshire as chair as swings to annual loss

Read more
4 Mar 2021 10:17

Spire Healthcare cautiously optimistic as revenues beat forecasts

(Sharecast News) - Spire Healthcare posted better-than-expected results on Thursday, after self-pay revenues increased in the second half.

Read more
25 Feb 2021 16:19

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
9 Feb 2021 13:46

Tuesday broker round-up

(Sharecast News) - Spirent Communications: Canaccord upgrades to buy with a target price of 275p.

Read more
9 Feb 2021 09:31

BROKER RATINGS: HSBC And ASOS Raised, DS Smith And Spire Cut

BROKER RATINGS: HSBC And ASOS Raised, DS Smith And Spire Cut

Read more
11 Jan 2021 09:54

UK BROKER RATINGS SUMMARY: Weir And Elementis Get Neutral Ratings

UK BROKER RATINGS SUMMARY: Weir And Elementis Get Neutral Ratings

Read more
5 Jan 2021 09:56

UK BROKER RATINGS SUMMARY: UBS Says Buy AVEVA; Investec Cuts Petrofac

UK BROKER RATINGS SUMMARY: UBS Says Buy AVEVA; Investec Cuts Petrofac

Read more
5 Jan 2021 08:05

LONDON BRIEFING: Morrisons Reports Pop In Champagne Sales At Christmas

LONDON BRIEFING: Morrisons Reports Pop In Champagne Sales At Christmas

Read more
21 Dec 2020 18:10

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.